Practice Management

The Future Is Precision Medicine

02/01/2017

Precision medicine aims to tailor medical treatments to each patient’s individual genetic profile and biology. Cancer researchers know that patients with particular mutations may respond better to certain types of drugs. Understanding tumor genetics helps biologists and geneticists create agents that target those tumors with greater efficacy.

G-202, a prodrug currently being investigated in Phase II clinical trials, is in a class of drugs that uses a biomarker for targeting. Identification of disease-specific biomarkers is essential to help predict patient reactions and speed up the process for treatment approval. Combining the biomarker research with proven immunotherapies will hopefully lead to increases in cancer survival rates.

For more videos, visit our partners at The Doctor's Channel.

Related Content

Inflammatory Bowel Disease
Inflammatory Bowel Disease
David Rubin, MD, on New and Emerging Therapies for IBD
07/25/2020
David Rubin, MD, review his talk at the virtual AIBD 2020 regional meeting July 25 on new and emerging therapeutics for inflammatory bowel disease.
07/25/2020
Gastroenterology
Gastroenterology
Choosing and Optimizing Therapy Today While Preparing for Tomorrow
08/06/2018
08/06/2018
Sleep Disorders
Albert Rizzo
Sleep Disorders
Albert Rizzo, MD, on Diagnosing Sleep Apnea
04/21/2018
In this video from the LUNG FORCE Expo, Albert Rizzo, MD, from Christiana Care's Pulmonary and Critical Care Medicine Section talks to us about diagnosing sleep apnea.
04/21/2018
Inflammatory Bowel Disease
Millie Long
Inflammatory Bowel Disease
Millie Long, MD, MPH, on Key Points of the ACG Guidelines for CD
05/30/2019
In this video, Millie Long, MD, MPH, from the University of North Carolina at Chapel Hill, discusses important updates from the American College of Gastroenterology guidelines on the management of Crohn...
05/30/2019
Gastrointestinal Disorders
Sara Horst
Gastrointestinal Disorders
Sara Horst, MD, MPH, on Managing Opportunistic Infections in IBD
07/03/2019
In this video, Sara Horst, MD, MPH, from Vanderbilt University Medical Center, discusses how she manages opportunistic infections among patients with IBD.
07/03/2019